Pirfenidone in the treatment of primary sclerosing cholangitis

Digestive Diseases and Sciences

Volumn 47, Issue 1, 2002, Pages 157-161

  Angulo, Paul ^a   MacCarty, Robert L ^a   Sylvestre, Pamela B ^a   Jorgensen, Roberta A ^a   Wiesner, Russell H ^a   LaRusso, Nicholas A ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Fibrosis; Medical therapy; Pirfenidone; Primary sclerosing cholangitis

Indexed keywords

ANTIFIBROTIC AGENT; PIRFENIDONE;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; LIVER BIOPSY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; PYRIDONES;

EID: 0036147240     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013240225965     Document Type: Article

References (20)

1. Primary sclerosing cholangitis
2. Pirfenidone reduces fibronectin synthesis by cultured human retinal pigmented epithelial cells
3. Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy
4. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney
5. Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translation level
6. Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone
7. Pirfenidone induces intracellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts
8. Pirfenidone: A novel pharmacological agent that inhibits leiomyoma cell proliferation and chollagen production
9. Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinolone
10. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone. Results of a prospective, open-label phase II study
11. Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats
12. Effects of pirfenidone and dermoid cyst fluid on adhesion formation
13. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis
14. Primary sclerosing cholangitis
15. Primary sclerosing cholangitis: Findings on cholangiography and pancreatography
16. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
17. Primary sclerosing cholangitis: Refinement and validation of survival models
18. Natural history and prognostic variables in primary sclerosing cholangitis
19. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis